CIBC Private Wealth Group
ARQT icon

CIBC Private Wealth Group’s Arcutis Biotherapeutics ARQT Stock Holding History

CIBC Private Wealth Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$245K Hold
8,434
– – ﹤0.01% 1105
2025
Q3 		$159K Buy
8,434
+186
+2% +$2.93K ﹤0.01% 1278
2025
Q2 		$116K Buy
8,248
+141
+2% +$1.98K ﹤0.01% 1328
2025
Q1 		$108K Buy
8,107
+325
+4% +$4.58K ﹤0.01% 1327
2024
Q4 		$119K Sell
7,782
-1,776
-19% -$19.5K ﹤0.01% 1354
2024
Q3 		$88.9K Buy
+9,558
New +$94.3K ﹤0.01% 1534

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC Private Wealth Group's ARQT Position: Q4 2025 in Review

CIBC Private Wealth Group held its Arcutis Biotherapeutics (ARQT) position steady in Q4 2025 at 8,434 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

CIBC Private Wealth Group first reported a position in ARQT in Q3 2024 and has held it in 6 quarters since. 283 funds tracked by Wall St. Rank hold ARQT as of Q4 2025.

  • CIBC Private Wealth Group held 8,434 shares of Arcutis Biotherapeutics worth $245K as of Q4 2025.
  • CIBC Private Wealth Group left its Arcutis Biotherapeutics share count unchanged in Q4 2025.
  • Arcutis Biotherapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1105 holding.
  • CIBC Private Wealth Group first reported a position in Arcutis Biotherapeutics in Q3 2024 and has held it in 6 quarters since.
  • 283 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.